Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domingo Gargallo-Viola

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methodsx|May 13, 2024
A novel high-throughput screening method for identifying compounds that inhibit plasmid conjugationJennifer Moussa, Domingo Gargallo-Viola, Line Elnif Thomsen
International Journal of Molecular Sciences|December 24, 2021
Uptake of Ozenoxacin and Other Quinolones in Gram-Positive BacteriaYuly López, Laura Muñoz, Domingo Gargallo-Viola, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat modelsElena Jimenez, Antonio Martínez, El Moukhtar Aliouat, et al.
Future Microbiology|May 29, 2019
Microbiological profile of ozenoxacinIan Morrissey, Rafael Cantón, Jordi Vila, et al.
Plos One|November 9, 2011
Thermodynamic concepts in the study of microbial populations: age structure in Plasmodium falciparum infected red blood cellsJordi Ferrer, Clara Prats, Daniel López, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 6, 2005
Improvement of detection specificity of Plasmodium-infected murine erythrocytes by flow cytometry using autofluorescence and YOYO-1María Belén Jiménez-Díaz, Joaquín Rullas, Teresa Mulet, et al.
Future Microbiology|May 11, 2018
Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolatesRafael Canton, Ian Morrissey, Jordi Vila, et al.
Diagnostic Microbiology and Infectious Disease|December 11, 2013
Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC valuesMarta Tato, Yuly López, Maria Isabel Morosini, et al.
Future Medicinal Chemistry|December 14, 2012
Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1José M Bueno, Esperanza Herreros, Iñigo Angulo-Barturen, et al.
Future Microbiology|May 11, 2018
Studies on articular and general toxicity of orally administered ozenoxacin in juvenile rats and dogsJorge Ignacio González Borroto, Malaika Sharon Awori, Luc Chouinard, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methodsx|May 13, 2024
A novel high-throughput screening method for identifying compounds that inhibit plasmid conjugationJennifer Moussa, Domingo Gargallo-Viola, Line Elnif Thomsen
International Journal of Molecular Sciences|December 24, 2021
Uptake of Ozenoxacin and Other Quinolones in Gram-Positive BacteriaYuly López, Laura Muñoz, Domingo Gargallo-Viola, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat modelsElena Jimenez, Antonio Martínez, El Moukhtar Aliouat, et al.
Future Microbiology|May 29, 2019
Microbiological profile of ozenoxacinIan Morrissey, Rafael Cantón, Jordi Vila, et al.
Plos One|November 9, 2011
Thermodynamic concepts in the study of microbial populations: age structure in Plasmodium falciparum infected red blood cellsJordi Ferrer, Clara Prats, Daniel López, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 6, 2005
Improvement of detection specificity of Plasmodium-infected murine erythrocytes by flow cytometry using autofluorescence and YOYO-1María Belén Jiménez-Díaz, Joaquín Rullas, Teresa Mulet, et al.
Future Microbiology|May 11, 2018
Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolatesRafael Canton, Ian Morrissey, Jordi Vila, et al.
Diagnostic Microbiology and Infectious Disease|December 11, 2013
Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC valuesMarta Tato, Yuly López, Maria Isabel Morosini, et al.
Future Medicinal Chemistry|December 14, 2012
Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1José M Bueno, Esperanza Herreros, Iñigo Angulo-Barturen, et al.
Future Microbiology|May 11, 2018
Studies on articular and general toxicity of orally administered ozenoxacin in juvenile rats and dogsJorge Ignacio González Borroto, Malaika Sharon Awori, Luc Chouinard, et al.
Pageof 2